Depsipeptide compound

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S300000, C514S002600, C514S009100

Reexamination Certificate

active

07098186

ABSTRACT:
The present invention relates to a novel compound which is useful as an agent for prevention and treatment of diseases associated with HDAC, in particular, tumor or cell proliferative diseases. The depsipeptide compound or its pharmaceutically acceptable salt of the present invention has a good HDAC inhibitory activity and an inhibitory activity of cell proliferation against human cancer cells and, therefore, is useful in treatment and improvement of diseases and pathogenic conditions associated with histone acetylation, in particular, tumor or cell proliferative diseases.

REFERENCES:
patent: 6670326 (2003-12-01), Nagai et al.
patent: 2003/0082054 (2003-05-01), Grylls et al.
patent: 2001-348340 (2001-12-01), None
patent: WO 00-42062 (2000-07-01), None
D. Voet and J.G. Voet. Biochemistry, 2nd Edition.(1995), p. 58.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Depsipeptide compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Depsipeptide compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Depsipeptide compound will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3626308

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.